1. Verdens helseorganisasjon (WHO).https://www.who.int/news-room/fact-sheets/detail/headache-disorders
2. Verdens helseorganisasjon (WHO). Burden of neurology diseases in EU: an analasys for Global Burden of Disease Study 2017. Deuschl G et al. Lancet 2020;5:551—67 https://www.thelancet.com/action/showPdf?pii=S2468-2667%2820%2930190-0
3. Folketelling. https://www.census.gov/popclock/
4. Steiner TJ m.fl. Cephalagia 2003; 23:519–527.
5. Nissan GR, Diamant ML. Diamond ML. Advances in migraine treatment. J Am Osteopath Assoc. 2005;105(4)(suppl 2):9S-15S
6. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(suppl 1):9-160.
7. BASH Guidelines 2010.https://headache.org.uk/landing-page/for-headache-sufferers/
8. Migraine Research Foundation. https://migraineresearchfoundation.org/about-migraine.html
9. Munataka J, Hazard E, Serrano D m.fl. Headache 2009;49:498–508
10. Katsarava Z et al. Defining the Differences Between Episodic Migraine and Chronic Migraine. Curr Pain Headache Rep. 2011
11. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394-402.
12. Verdens helseorganisasjon (WHO) and European Headache Federation (EHF). J Headache Pain 2007;8:S1–S47.
13. Migraine in primary care advisors (MIPCA). Treatment guidelines for migraine. 2006. http://www.mipca.org.uk/guidelines_mig.htm
14. HelseNorge. https://www.helsenorge.no/sykdom/skader-og-sykdommer-i-hjernen/migrene/
15. Lipton RB, Dodick D, Sadovsky R, et al. ID Migraine validation study. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology 2003;61:375–82.
16. Hagen K et al: Time trends of major headache diagnoses and predictive factors. Data from three Nord-Trøndelag health surveys. The Journal of Headache and Pain, (2022) 21:24.
17. Steiner, T.J., Stovner, L.J. Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19, 109–117 (2023).
© Hjemmesiden er utviklet av AbbVie.
NO-NEUM-240002 des-2024